Applied UV (NASDAQ: AUVI) Announces International Dealer Awarded Sole Source Provider Contract for Airocide’s FDA Class II Listed Medical Device
Airocide to be Deployed in Pakistan Government Hospitals Expands Global Footprint with Distribution Now in 52 Countries MOUNT VERNON, N.Y., June 09, 2022–Applied UV, Inc. (NASDAQ: AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company […]